Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$8.52
0.070.83%
Last update: Dec 12, 4:00 PM
Comments
Loading...
Cartesian Therapeutics (RNAC) Stock Price, Quote, News & History
RNACNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Cartesian Therapeutics (RNAC) stock?
You can purchase shares of Cartesian Therapeutics (NASDAQ:RNAC) through any online brokerage.
Who are Cartesian Therapeutics (RNAC) competitors?
Other companies in Cartesian Therapeutics’s space includes: Cabaletta Bio Inc (NASDAQ:CABA), Innate Pharma SA (NASDAQ:IPHA), Humacyte Inc (NASDAQ:HUMA), ProQR Therapeutics NV (NASDAQ:PRQR) and Voyager Therapeutics Inc (NASDAQ:VYGR).
What is the forecast, or price target, for Cartesian Therapeutics (RNAC) stock?
Cartesian Therapeutics has a consensus price target of $39.25.
What is the current price for Cartesian Therapeutics (RNAC)?
The stock price for Cartesian Therapeutics (NASDAQ: RNAC) is $8.52 last updated December 12, 2025 at 4:00 PM EST.
Does Cartesian Therapeutics (RNAC) pay a dividend?
There are no upcoming dividends for Cartesian Therapeutics.
When is Cartesian Therapeutics (NASDAQ:RNAC) reporting earnings?
Cartesian Therapeutics does not have any upcoming earnings scheduled.
Is Cartesian Therapeutics (RNAC) going to split?
There is no upcoming split for Cartesian Therapeutics.
What sector and industry does Cartesian Therapeutics (RNAC) operate in?
Cartesian Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
